BioSkryb Genomics  

• Booth: 803

BioSkryb Genomics is a rapidly growing organization transforming the single-cell analysis market through products, custom services, and computational biology. We enable the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics. At its core, we empower the transformation of cellular discovery and disease management through unequivocal analysis of individual cells to ultimately help researchers and clinicians better understand and treat complex diseases in areas like oncology/immunology, cell and gene therapy, and neurology. We set ourselves apart from other single-cell technology providers through our patented genome amplification method, primary template-directed amplification, which allows the most complete and accurate coverage of the genome at the single cell level. We have expanded into multiomic analysis and are the only company that enables a view of the genome, transcriptome, and targeted proteins within each individual cell. Our technology has been used in ~44 publications and has been awarded 4 key patents in key markets across the globe. Our growth is being driven by adoption in some of the largest sequencing and research centers in the world, biopharma collaborations, and commercial partnerships.

Brands: ResolveDNA™ ResolveOME™ BaseJumper™